申请人:Praxis Biotech LLC
公开号:US20190185451A1
公开(公告)日:2019-06-20
Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
描述了用于调节成纤维细胞活化蛋白(FAP)的化合物和组合物。这些化合物和组合物可能被用作治疗疾病的治疗剂,包括高增殖性疾病。